Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
Holding APRE?
Track your performance easily

Aprea Therapeutics (APRE) Ownership - Who Owns Aprea Therapeutics?

430 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 14, 2024
xxxxxxxxxxxxx
$50009
Mar 14, 2024
xxxxxxxxxxxxx
$50009
Mar 14, 2024
John P. Hamill
Srvp/cfo/prin Fin & Acct Ofcr
xxxxxxxxxxxxx
$7363
Mar 14, 2024
Oren Gilad
President & Ceo,director
xxxxxxxxxxxxx
$14580

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
116,459Institution2.14%333,073
114,842Institution2.11%328,448
23,132Institution0.43%66,158
6,787Institution0.12%19,411
2,358Institution0.04%6,744
996Institution0.02%2,849

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
114,842Institution2.11%328,448
23,132Institution0.43%66,158
2,358Institution0.04%6,744
996Institution0.02%2,849

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
87,897Institution1.62%325,219
28,562Institution0.53%105,679
5,083Institution0.09%14,537
1,295Institution0.02%3,898
409Institution<0.01%1,170

FAQ

Who Owns Aprea Therapeutics Inc (APRE)?
Currently, no data Available
What percentage of Aprea Therapeutics Inc (APRE) stock is held by institutional investors?
Currently, no data Available
What percentage of Aprea Therapeutics Inc (APRE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Aprea Therapeutics Inc (APRE)?
Vanguard owns the most shares of Aprea Therapeutics Inc (APRE).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis